Evidence map›Paper›PMID 39653819›Full record

ArticleNature methods2025

ProHap enables human proteomic database generation accounting for population diversity.

Jakub Vašíček, Ksenia G Kuznetsova, Dafni Skiadopoulou, Lucas Unger, Simona Chera, Luiza M Ghila, Nuno Bandeira, Pål R Njølstad, Stefan Johansson, Stefan Bruckner and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature methods, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jakub VašíčekMohn Center for Diabetes Precision Medicine, Department of Clinical Science, University of Bergen, Bergen, Norway.ORCID http://orcid.org/0000-0003-2340-0560
Ksenia G KuznetsovaMohn Center for Diabetes Precision Medicine, Department of Clinical Science, University of Bergen, Bergen, Norway.ORCID http://orcid.org/0000-0001-7447-4047
Dafni SkiadopoulouMohn Center for Diabetes Precision Medicine, Department of Clinical Science, University of Bergen, Bergen, Norway.ORCID http://orcid.org/0000-0001-5572-0070
Lucas UngerMohn Center for Diabetes Precision Medicine, Department of Clinical Science, University of Bergen, Bergen, Norway.
Simona CheraMohn Center for Diabetes Precision Medicine, Department of Clinical Science, University of Bergen, Bergen, Norway.ORCID http://orcid.org/0000-0001-6310-3486
Luiza M GhilaMohn Center for Diabetes Precision Medicine, Department of Clinical Science, University of Bergen, Bergen, Norway.ORCID http://orcid.org/0000-0001-7173-6312
Nuno BandeiraUniversity of California, San Diego, La Jolla, CA, USA.ORCID http://orcid.org/0000-0001-8385-3655
Pål R NjølstadMohn Center for Diabetes Precision Medicine, Department of Clinical Science, University of Bergen, Bergen, Norway.ORCID http://orcid.org/0000-0003-0304-6728
Stefan JohanssonMohn Center for Diabetes Precision Medicine, Department of Clinical Science, University of Bergen, Bergen, Norway.ORCID http://orcid.org/0000-0002-2298-7008
Stefan BrucknerInstitute for Visual and Analytic Computing, University of Rostock, Rostock, Germany.ORCID http://orcid.org/0000-0002-0885-8402
Lukas KällScience for Life Laboratory, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH - Royal Institute of Technology, Stockholm, Sweden.ORCID http://orcid.org/0000-0001-5689-9797
Marc VaudelMohn Center for Diabetes Precision Medicine, Department of Clinical Science, University of Bergen, Bergen, Norway. marc.vaudel@uib.no.ORCID http://orcid.org/0000-0003-1179-9578

Funding

EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 293574Knut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation) Wallenberg AI, Autonomous Systems and Software Program (WASP)Norges Forskningsråd (Research Council of Norway) 240413Norges Forskningsråd (Research Council of Norway) 314397Novo Nordisk Fonden (Novo Nordisk Foundation) 54741Novo Nordisk Fonden (Novo Nordisk Foundation) NNF21OC0067325
6 · The paper itself

Abstract

Amid the advances in genomics, the availability of large reference panels of human haplotypes is key to account for human diversity within and across populations. However, mass spectrometry-based proteomics does not benefit from this information. To address this gap, we introduce ProHap, a Python-based tool that constructs protein sequence databases from phased genotypes of reference panels. ProHap enables researchers to account for haplotype diversity in proteomic searches.

Indexed as

Databases, ProteinGenetic VariationProteomicsSoftwareHaplotypesHumans

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.